External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology SUO 2025
Roche and Genentech at

SUO 2025

December 02 - December 05
Phoenix, USA
suonet.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:20 PM
Duration 25mins Phoenix
Circulating tumor DNA-guided adjuvant atezolizumab vs placebo in patients with muscle-invasive bladder cancer after radical cystectomy: Exploratory subgroup analysis of the Phase 3 IMvigor011 trial
Jürgen E. Gschwend, Joaquim Bellmunt, Cagatay Arslan, Flora Zagouri, Mustafa Özgüroğlu, Hubert Kübler, Yohann Loriot, Florian Seseke, Ye Tian, Kazuyoshi Iijima, Hong Luo, Hakim Mahammedi, Masafumi Nakamura, Suguru Shirotake, Friedemann Zengerling, Shifeng Mao, Shilpa Gupta, Wei Zou, Elizabeth Steinberg, Thomas Powles
Oncology | Urinary Bladder Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.